[Value of successive use of aldactone and aldactacine in the management of congestive heart failure involving at the outset hypokalemia with or without cardiac rhythm disorders].
D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000150:complications; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007008:Hypokalemia / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D004338:Drug Combinations; D013449:Sulfonamides; D013148:Spironolactone; C026063:spironolactone, althiazide drug combination
Intérêt de l'utilisation successive d'aldactone et d'aldactazine dans le traitement des insuffisances cardiaques congestives comportant au départ und hypokaliémie sans ou aved troubles du rythme cardiaque.